Vision Point Advisory Group, LLC Bristol Myers Squibb CO Transaction History
Vision Point Advisory Group, LLC
- $264 Million
- Q4 2024
A detailed history of Vision Point Advisory Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Vision Point Advisory Group, LLC holds 25,677 shares of BMY stock, worth $1.52 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
25,677
Previous 19,674
30.51%
Holding current value
$1.52 Million
Previous $1.02 Million
42.63%
% of portfolio
0.55%
Previous 0.37%
Shares
11 transactions
Others Institutions Holding BMY
# of Institutions
2,612Shares Held
1.46BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$11.1 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.38 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.49 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.61 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.61 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $126B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...